Reducing False Positives through the Application of Fluorescence Lifetime Technology: A Comparative Study Using TYK2 Kinase as a Model System

This publication has 35 references indexed in Scilit:

• Approaches to discover non-ATP site kinase inhibitors
  MedChemComm, 2012
• Enabling Lead Discovery for Histone Lysine Demethylases by High-Throughput RapidFire Mass Spectrometry
  SLAS Discovery, 2012
• Redox-active nuisance screening compounds and their classification
  Drug Discovery Today, 2011
• Comparing Signaling Networks between Normal and Transformed Hepatocytes Using Discrete Logical Models
  Cancer Research, 2011
• A Fluorescence Lifetime-Based Assay for Abelson Kinase
  SLAS Discovery, 2011
• Apparent activity in high-throughput screening: origins of compound-dependent assay interference
  Current Opinion in Chemical Biology, 2010
• HTRF: A Technology Tailored for Drug Discovery - A Review of Theoretical Aspects and Recent Applications
  Current Chemical Genomics, 2009
• A Fluorescence Lifetime-Based Assay for Protease Inhibitor Profiling on Human Kallikrein 7
  SLAS Discovery, 2009
• A Fluorescence Lifetime–Based Binding Assay to Characterize Kinase Inhibitors
  SLAS Discovery, 2007
• Attenuation of Murine Collagen-Induced Arthritis by a Novel, Potent, Selective Small Molecule Inhibitor of IκB Kinase 2, TPCA-1 (2-[(Aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), Occurs via Reduction of Proinflammatory Cytokines and Antigen-Induced T Cell Proliferation
  The Journal of Pharmacology and Experimental Therapeutics, 2005